Is Y90 Radioembolization Superior or Comparable to Transarterial Chemoembolization for Treating Hepatocellular Carcinoma?

被引：3
|
作者：
Pan, Ling-Hui [1 ]
Zhao, Chang [2 ]
Ma, Yi-Long [2 ]
机构：
[1] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Anesthesiol, Nanning, Peoples R China
[2] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Invas Technol, Nanning, Peoples R China
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 06期
基金：
中国国家自然科学基金;
关键词：
HEPATIC RESECTION;
D O I：
10.1053/j.gastro.2016.10.048
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1627 / +
页数：2
相关论文
共 50 条
  • [21] Long-term outcome analysis of Y90 radioembolization in hepatocellular carcinoma.
    Alder, Laura
    Nguyen, Matthew
    Qu, James
    Lee, Hannah
    Thacker, Leroy R.
    Dougherty, Sean
    Poklepovic, Andrew Stewart
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection
    Rehan Ali
    Ahsun Riaz
    Ahmed Gabr
    Nadine Abouchaleh
    Ronald Mora
    Ali Al Asadi
    Juan Carlos Caicedo
    Michael Abecassis
    Nitin Katariya
    Haripriya Maddur
    Laura Kulik
    Robert J. Lewandowski
    Riad Salem
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 2195 - 2202
  • [23] Radioembolization with Y90 as bridge to liver transplantation or resection for intermediate stage hepatocellular carcinoma
    Labgaa, I.
    Tabrizian, P.
    Titano, J.
    Florman, S.
    Kim, E.
    Schwartz, M.
    Melloul, E.
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 20 - 21
  • [24] Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection
    Ali, Rehan
    Riaz, Ahsun
    Gabr, Ahmed
    Abouchaleh, Nadine
    Mora, Ronald
    Al Asadi, Ali
    Caicedo, Juan Carlos
    Abecassis, Michael
    Katariya, Nitin
    Maddur, Haripriya
    Kulik, Laura
    Lewandowski, Robert J.
    Salem, Riad
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (13) : 2195 - 2202
  • [25] EFFICACY OF YTTRIUM90 ( Y90) RADIOEMBOLIZATION FOR DOWNSTAGING OR BRIDGE TO TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Ghattu, Meghana
    Engstrom, Bjorn
    Castro-Pearson, Sandra
    Lake, John R.
    HEPATOLOGY, 2023, 78 : S1838 - S1839
  • [26] Transarterial Chemoembolization and 90Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease
    Fidelman, Nicholas
    Kerlan, Robert K., Jr.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 205 (04) : 742 - 752
  • [27] Hepatic resection is superior to transarterial chemoembolization for treating intermediate-stage hepatocellular carcinoma
    Zhong, Jian-Hong
    Peng, Ning-Fu
    You, Xue-Mei
    Ma, Liang
    Li, Le-Qun
    LIVER INTERNATIONAL, 2017, 37 (07) : 1083 - 1084
  • [28] Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality
    Kim, Do Young
    Han, Kwang-Hyub
    HEPATOLOGY INTERNATIONAL, 2016, 10 (06) : 883 - 892
  • [29] TRANSARTERIAL CHEMOEMBOLIZATION VERSUS TRANSARTERIAL RADIOEMBOLIZATION FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA: A META-ANALYSIS
    Brown, Andrew
    Kassab, Ihab A.
    Chen, Vincent L.
    Townsend, Whitney A.
    Singal, Amit G.
    Parikh, Neehar D.
    HEPATOLOGY, 2019, 70 : 234A - 235A
  • [30] A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma
    Yu, Shawn
    Yu, Menggang
    Keane, Barry
    Mauro, David M.
    Helft, Paul R.
    Harris, William P.
    Sanoff, Hanna K.
    Johnson, Matthew S.
    O'Neil, Bert
    McRee, Autumn Jackson
    Somasundaram, Ashwin
    ONCOLOGIST, 2024, 29 (03): : 270 - +
12345